BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 8826937)

  • 1. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
    Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
    Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
    Alsalameh S; Firestein GS; Oez S; Kurrle R; Kalden JR; Burmester GR
    J Rheumatol; 1994 Jun; 21(6):993-1002. PubMed ID: 7932447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
    Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The in situ analysis of cytokine mRNA expression in immunological microenvironment about non-small cell lung cancer].
    Chen HW; Li R; Li R; Lai BC; Si LS; Wang YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):763-6. PubMed ID: 16256041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.
    Schwartzentruber DJ; Topalian SL; Mancini M; Rosenberg SA
    J Immunol; 1991 May; 146(10):3674-81. PubMed ID: 1902860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effector cells in head and neck cancer.
    Vitolo D; Letessier EM; Johnson JT; Whiteside TL
    J Natl Cancer Inst Monogr; 1992; (13):203-8. PubMed ID: 1356393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
    Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
    Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.
    Arnold R; Humbert B; Werchau H; Gallati H; König W
    Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
    Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A
    Cancer; 2007 Feb; 109(3):556-65. PubMed ID: 17177206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.
    Rumbaugh KP; Colmer JA; Griswold JA; Hamood AN
    Cytokine; 2001 Nov; 16(4):160-8. PubMed ID: 11792126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
    Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
    Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.